Vision-Sciences Purchased Assets of a Florida-Based Speech Pathology Company

Vision-Sciences, Inc., announced today that it has purchased the assets of BEST Dysphagia Management Services, Inc, a Florida-based speech pathology company which specializes in providing the Bedside Endoscopic Swallowing Test to nursing homes, rehabilitation centers and assisted living settings. Vision-Sciences purchased the assets via its new wholly-owned subsidiary BEST DMS, Inc., and will continue to operate the business under the direction of Ms. Carol Ghiglieri-Winchester, MS, SLP, CCC, President and Founder of BEST Dysphagia Management Services, Inc.

"We are delighted to have Carol and her team join the Vision-Sciences team" stated Ron Hadani, CEO of Vision-Sciences. "BEST DMS will allow us access to new markets, including the geriatric market, nursing homes and rehabilitation centers. Our new superior digital videoscopes with their light-weight, portable control unit with its integrated display, coupled with our EndoSheath(r) products, are uniquely suited to the high-quality imaging and portability requirements of the markets targeted by BEST DMS. We are confident that our scopes and EndoSheath(r) technology will become the new standard and leading diagnostic tool for patients suffering from swallowing disorders, or dysphagia. We also expect that BEST DMS will contribute to our future revenue growth, as it expands its operations throughout the U.S."

Carol Winchester, President of BEST DMS, added: "Joining Vision-Sciences with its superior videoscopes and its EndoSheath(r) technology will allow us to perform more procedures per day, and expand our business to more states, where our current client-base operates additional assisted-living and nursing home facilities. The geriatric population, for which our service is most valuable, is predicted to double in the next 15 years and BEST DMS is positioning itself to grow with Vision-Sciences through this acquisition. This growth will allow us to service the increasing needs and improve diagnostic capabilities, the comfort of care and quality of life for a significant number of patients today as well as in the years ahead."